CutiaTx
IPOBetter by Science
CutiaTx was founded in 2019, is headquartered in Shanghai, China, and lists 201–500 employees.
- Headquarters
- Shanghai
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- cutiatx.com
- Type
- Public
About
Cutia Therapeutics (SEHK: 2487) is a Shanghai-based, R&D-driven biopharmaceutical holding company founded in 2019 and dedicated to the dermatology treatment and care market. The company develops, manufactures, and commercializes a comprehensive suite of solutions for skin and scalp diseases using its proprietary CATAME® technology platform, targeting areas including scalp conditions, skin diseases, topical anesthesia, and localized treatments. Cutia went public on the Hong Kong Stock Exchange in June 2023 and employs approximately 304 people, with R&D, manufacturing, and commercial operations spanning Shanghai, Beijing, and Wuxi.
Summary
CutiaTx is a Biotech company based in Shanghai, China, founded in 2019. It lists 201–500 employees.
Exit History
Jun 2023
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cutiatx"><img src="https://indexed.vc/api/badge/company/cutiatx" alt="CutiaTx on Indexed.vc" width="260" height="76" /></a>